Details for New Drug Application (NDA): 019655
✉ Email this page to a colleague
The generic ingredient in RETROVIR is zidovudine. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the zidovudine profile page.
Summary for 019655
Tradename: | RETROVIR |
Applicant: | Viiv Hlthcare |
Ingredient: | zidovudine |
Patents: | 0 |
Pharmacology for NDA: 019655
Mechanism of Action | Nucleoside Reverse Transcriptase Inhibitors |
Medical Subject Heading (MeSH) Categories for 019655
Suppliers and Packaging for NDA: 019655
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RETROVIR | zidovudine | CAPSULE;ORAL | 019655 | NDA | ViiV Healthcare Company | 49702-211 | 49702-211-20 | 100 CAPSULE in 1 BOTTLE (49702-211-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Mar 19, 1987 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 019655
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viiv Hlthcare | RETROVIR | zidovudine | CAPSULE;ORAL | 019655-001 | Mar 19, 1987 | ⤷ Subscribe | ⤷ Subscribe |
Viiv Hlthcare | RETROVIR | zidovudine | CAPSULE;ORAL | 019655-001 | Mar 19, 1987 | ⤷ Subscribe | ⤷ Subscribe |
Viiv Hlthcare | RETROVIR | zidovudine | CAPSULE;ORAL | 019655-001 | Mar 19, 1987 | ⤷ Subscribe | ⤷ Subscribe |
Viiv Hlthcare | RETROVIR | zidovudine | CAPSULE;ORAL | 019655-001 | Mar 19, 1987 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription